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Letters to the Editor
Cautious Interpretation of
Data Regarding Myopericarditis
Associated With Smallpox Vaccination
We congratulate Cassimatis et al. (1) for their excellent review of
myopericarditis associated with smallpox vaccination. We suggest
a different interpretation of the data regarding some important
issues.
First, the true incidence of myopericarditis secondary to small-
pox vaccination with Dryvax (NYBOH strain) vaccine remains
unknown and it is likely higher than the quoted rates of one case
per 9,360 (1), 10,000 (2), or 12,819 (3) vaccinations, which
represent the recognition of overt, symptomatic myopericarditis in
a highly selected, very fit military population. We suspect myo-
pericarditis is underdiagnosed in this population because of the
wide spectrum of presenting clinical symptoms and signs that
confound accurate diagnosis, the potential for minimal or no-
symptom cases that could lead to missed cases, and the character-
istics of young, volunteer, military personnel who could conceiv-
ably overlook or minimize symptoms that do not limit their service
duties. A higher rate of myopericarditis is supported by the 2% to
3% incidence of electrocardiographic changes after smallpox vac-
cination in Swedish military personnel in the 1960s (4,5). Impor-
tantly, a higher incidence of myopericarditis would likely be
recognized if mass smallpox vaccination were applied to the
general population with higher prevalence rates of cardiovascular
and immunologic disease, in an attempt to protect citizens against
smallpox bioterrorism.
Second, the long-term sequelae of myopericarditis due to
smallpox vaccination remain unknown. Subclinical or overt abnor-
malities due to vaccinia viremia or its immunologic responses, such
as direct viral toxicity or immune-mediated myocyte necrosis,
persistent myocardial inflammatory infiltrates, or development of
myocardial fibrosis, may manifest years later, with ventricular
dysfunction, conduction system abnormalities, or sudden death.
Although almost all recently vaccinated patients with myopericar-
ditis recovered clinically, the possibility of residual low-grade
myocardial inflammation and fibrosis cannot be excluded or
prevented.
Third, endomyocardial biopsy probably is of greater than
“limited utility” after smallpox vaccination. We advocate endo-
myocardial biopsy for all patients with suspected new-onset ven-
tricular dysfunction (ejection fraction 45%) and symptoms of
heart failure after smallpox vaccination. The rationale for this
approach is the documentation of possible steroid responsive
eosinophilic myocarditis, which occurred in one recent patient
after smallpox vaccination, and the need to exclude uncontrolled
vaccinia virus replication within the myocardial that may be
responsive to immune globulin. Endomyocardial biopsy under
echocardiographic guidance is a relatively safe procedure in expe-
rienced hands and may provide a definitive actionable diagnosis in
high-risk patients (6).
It is a profound tragedy that vaccination against an eradicated
disease whose elimination marked the single greatest human
success against a communicable disease is now required for U.S.
soldiers because of the threat of biowarfare. Current smallpox
vaccine appears to carry significant risks of serious adverse events.
The true incidence and long-term sequalae of current smallpox
vaccine remain unknown.
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REPLY
We appreciate the comments on our review (1) of myopericarditis
associated with smallpox vaccination. The recently published rates
of myopericarditis may indeed be underestimates, for they are
based on reporting of clinical encounters with symptomatic pa-
tients from an occupational cohort, as we noted previously (2). To
better assess the true incidence rate, we will soon enroll volunteers
in a prospective trial of smallpox vaccinees with baseline and
follow-up electrocardiography, laboratory markers, and question-
naires.
We described the need to follow patients diagnosed with
postvaccinial myopericarditis to establish whether long-term se-
quelae exist (1), and we recently have published the results of such
follow-up (3). On the basis of these data, long-term sequelae are
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not yet apparent, and recovery rates based on objective markers are
high. We intend to continue follow-up for the next two to five
years, while looking for evidence of any long-term sequelae.
The utility of endomyocardial biopsy after smallpox vaccination
is uncertain. Given the inherent risks and low diagnostic yield of
endomyocardial biopsy (1,4), as well as the high likelihood of full
objective recovery after smallpox vaccine-associated myopericardi-
tis (3), we would be remiss to recommend a potentially harmful
procedure in all patients with depressed left ventricular function.
Although there has been one case of eosinophilic myocarditis
that improved shortly after receiving corticosteroids (5), this one
case is insufficient to conclude that corticosteroids will always be
beneficial, even when eosinophils are seen on biopsy. However, the
possibility that corticosteroids may uniquely benefit patients with
eosinophilic myocarditis does warrant continued evaluation.
Therefore, although we support endomyocardial biopsy in patients
with symptomatic moderate or worse left-ventricular dysfunction
related temporally to smallpox vaccination, we caution that every
case must be considered individually.
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Pacemaker Complication
During Magnetic Resonance Imaging
The article by Martin et al. (1) suggesting that magnetic resonance
imaging (MRI) examinations are safe in qualified pacemaker
patients should lead to improved care, especially for cancer
patients. Encouraged by this article, we have taken two patients
into a Signa LX EchoSpeed 1.5-T MRI (GE Medical Systems,
Milwaukee, Wisconsin). Our second patient experienced difficul-
ties not previously noted, demonstrating the need for continued
caution when performing these exams.
A 48-year-old man with a left-sided, dual-chamber pacemaker
placed on August 1, 1997, for neurogenic syncope (Thera DR
7960i, Medtronic Corp., Minneapolis, Minnesota) had metastatic
multiple myeloma and significant pain. The MRI was performed
to evaluate lower extremity neurologic deficits after attempted
intrathecal catheter implantation.
The thoracic and lumbar spine regions were evaluated by
sagittal fast spin echo (FSE) T2-weighted pulse sequences with fat
saturation and pre/post contrast T1-weighted FSE pulse sequences
in the sagittal and axial planes. Compared to previous computed
tomography (CT) myelogram, MRI revealed more extensive cord
compression at T9–10 from epidural tumor. The MRI demon-
strated no epidural hematoma, possibly preventing an unnecessary
laminectomy. A CT examination performed one month previ-
ously, because of pacemaker contraindication to MRI, demon-
strated no epidural involvement.
Pacemaker evaluation immediately before MRI showed ade-
quate battery voltage and impedance (Fig. 1) with DDDR pacing
(lower rate 60, upper sensor and tracking rates 135 beats/min).
M.A.R. (an anesthesiologist “facile in the ways of pacemaker
programming”) disabled pacemaker rate responsiveness and mon-
itored the patient with pulse oximetry plethysmography and
electrocardiography (Millennia 3155 MVS monitor, In Vivo Re-
search, Orlando, Florida). This monitor has no pacemaker artifact
enhancement in the remote (MRI) mode.
Upon entering the MRI room, pacemaker magnet mode was
activated (DOO pacing, 85 beats/min) until patient alignment
with the MRI tunnel (heart rate returned to 74 beats/min). During
MRI, pacing appeared to remain in DDD mode, with heart rates
between 68 and 82 beats/min. Occasional pseudofusion beats were
noted, but the ECG tracing was unreliable during MRI sequences.
PVCs were noted during and between MRI scan cycles. No
medication was given, and the patient did not complain of
palpitations or chest pain (although he had back pain). He was
quickly removed from the MRI upon completion of the 1.5-h
exam.
Immediate pacemaker interrogation revealed onset of elective
replacement (ERI) with a programming change to VVI pacing at 65
beats/min despite normal battery voltage and impedance (Fig. 2).
This change eliminated all pacemaker diagnostic data storage. The
“STATUS RESET” function in the programmer returned the pace-
Figure 1. Battery and pacemaker lead data from a Medtronic Thera Model
7960i dual-chamber pacemaker immediately before magnetic resonance
imaging of the thoracic and lumbar spine in a 1.5-T magnetic resonance
imager. The battery showed acceptable voltage and impedance with a
21-month life expectancy.
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